Antioxidant and Anti-Inflammatory Activities of High-Glucosinolate-Synthesis Lines of Brassica rapa
Antioxidants · 30.08.2023 · 12 (9) · 1693
DOI: 10.3390/antiox12091693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 30.08.2023. Verfasst von Hyunjin Choi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science and Technology, Kyung Hee University, Seoul 02447, Republic of Korea. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rural Development Administration, National Research Foundation of Korea, National Institute of Agricultural Sciences.
Abstract (Originalsprache)
Excessive oxidative stress and inflammatory responses are associated with the development of various diseases, including cancer. Glucosinolates (GSLs) are phytochemicals known for their antioxidant properties, and doubled haploid lines (DHLs) of Brassica rapa with high GSL contents (HGSL) were intentionally developed from two edible subspecies of Brassica rapa: B. rapa subsp. trilocularis and B. rapa subsp. chinensis. The purpose of the present study is to assess the capacity of HGSL DHLs to mitigate oxidative stress and inflammation in lipopolysaccharide (LPS)-stimulated RAW264.7 cells, compared to pak choi as a parental control. Our findings demonstrate that HGSL DH lines effectively suppressed the expression of inducible nitric oxide synthase, leading to the reduced levels of nitric oxide at non-toxic concentrations. Additionally, these lines exhibited scavenging activity against reactive oxygen species and free radicals. The enhanced antioxidant capacity of HGSL DHLs was mechanistically attributed to the upregulation of antioxidant enzymes, such as NADPH quinone oxidoreductase 1 (NQO1), the glutamate–cysteine ligase catalytic subunit (GCLC), and heme oxygenase-1 (HMOX1). Furthermore, we confirmed that these effects were mediated through the nuclear factor erythroid 2-related factor 2 (NRF2) signaling pathway via p38 phosphorylation. Moreover, HGSL DHLs demonstrated inhibitory effects on pro-inflammatory cytokines and signal transducers and activators of transcription 3 (STAT3) phosphorylation. Collectively, our results indicate that HGSL DHLs possess better antioxidant and anti-inflammatory properties compared to the parental control pak choi in LPS-stimulated RAW264.7 cells, suggesting that HGSL DHLs of Brassica rapa could be considered as a beneficial daily vegetable for reducing the risk of inflammation-associated diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Science and Technology, Kyung Hee University, Seoul 02447, Republic of Korea.
- Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
- Genomic Division, Department of Agricultural Bio-Resources, National Institute of Agricultural Sciences, Rural Development Administration, Jeonju 54874, Republic of Korea.
ORCID-Profile: Sanghee Han, In Jin Ha, Jung Sun Kim, Seok-Geun Lee
Förderung
- Rural Development Administration
- National Research Foundation of Korea
- National Institute of Agricultural Sciences
Zitieren
APA
Choi, H., Kim, H., Han, S., Park, H. W., Ha, I. J., Kim, J. S., & Lee, S. G. (2023). Antioxidant and Anti-Inflammatory Activities of High-Glucosinolate-Synthesis Lines of Brassica rapa. Antioxidants, 12(9), 1693. https://doi.org/10.3390/antiox12091693
Vancouver
Choi H, Kim H, Han S, Park HW, Ha IJ, Kim JS, et al. Antioxidant and Anti-Inflammatory Activities of High-Glucosinolate-Synthesis Lines of Brassica rapa. Antioxidants. 2023;12(9):1693. doi:10.3390/antiox12091693
BibTeX
@article{Choi2023,
author = {Choi, Hyunjin and Kim, Hail and Han, Sanghee and Park, Hyun Woo and Ha, In Jin and Kim, Jung Sun and Lee, Seok-Geun},
title = {Antioxidant and Anti-Inflammatory Activities of High-Glucosinolate-Synthesis Lines of Brassica rapa},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {9},
pages = {1693},
doi = {10.3390/antiox12091693}
}
EUVIMED